Cargando…

Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis

Collagen triple helix repeat containing-1 (CTHRC1) is a secreted glycoprotein that activates the planar cell polarity pathway of Wnt signaling. Using microarray analysis, we found that the CTHRC1 gene is overexpressed in hepatocellular carcinoma (HCC). The level of CTHRC1 mRNA was measured in 201 su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Ling, Wang, Ting-Huang, Hsu, Hey-Chi, Yuan, Ray-Hwang, Jeng, Yung-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726622/ https://www.ncbi.nlm.nih.gov/pubmed/23922981 http://dx.doi.org/10.1371/journal.pone.0070324

Ejemplares similares

Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion
por: Lee, Yu-Hsin, et al.
Publicado: (2016)

High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2015)

Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2018)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway
por: Zheng, Mei, et al.
Publicado: (2019)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma
por: Jang, Se Young, et al.
Publicado: (2016)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma
por: Wang, Yunpeng, et al.
Publicado: (2017)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer
por: Ke, Zunfu, et al.
Publicado: (2014)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
por: Yuan, Ray-Hwang, et al.
Publicado: (2013)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Ha, Sang Yun, et al.
Publicado: (2016)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma
por: Wu, Han, et al.
Publicado: (2016)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

The role of CTHRC1 in promotion of cutaneous wound healing
por: Duan, Xianlan, et al.
Publicado: (2022)

NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Jing, Ji-sheng, et al.
Publicado: (2018)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion
por: Xing, Quan-tai, et al.
Publicado: (2014)

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma
por: Zhang, Yaojun, et al.
Publicado: (2017)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2020)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
por: Chen, Yu-Ling, et al.
Publicado: (2013)

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
por: Xiao, Siyu, et al.
Publicado: (2020)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mheveao3b835hevllvib071opm